skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 195,315  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Oncology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
Material Type:
Article
Add to My Research

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

Journal of clinical oncology, 2020-09, Vol.38 (25), p.2830-2838 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.00818 ;PMID: 32484754

Full text available

2
Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
Material Type:
Article
Add to My Research

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2325-2332 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.67.0448 ;PMID: 27044935

Full text available

3
Cancer statistics, 2023
Material Type:
Article
Add to My Research

Cancer statistics, 2023

CA: a cancer journal for clinicians, 2023-01, Vol.73 (1), p.17-48 [Peer Reviewed Journal]

2023 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan/Feb 2023 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21763 ;PMID: 36633525

Full text available

4
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Material Type:
Article
Add to My Research

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Journal of clinical oncology, 2021-09, Vol.39 (27), p.2991-3001 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03555 ;PMID: 34292792

Full text available

5
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
Material Type:
Article
Add to My Research

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

Journal of clinical oncology, 2021-08, Vol.39 (24), p.2656-2666 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.21.00612 ;PMID: 33979178

Full text available

6
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
Material Type:
Article
Add to My Research

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2125-2132 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.72.1316 ;PMID: 28441111

Full text available

7
Colorectal Cancer Incidence Patterns in the United States, 1974-2013
Material Type:
Article
Add to My Research

Colorectal Cancer Incidence Patterns in the United States, 1974-2013

JNCI : Journal of the National Cancer Institute, 2017-08, Vol.109 (8) [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2017 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djw322 ;PMID: 28376186

Full text available

8
Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer
Material Type:
Article
Add to My Research

Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer

Journal of clinical oncology, 2016-06, Vol.34 (18), p.2157-2164 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2015.65.9128 ;PMID: 27138577

Full text available

9
International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013
Material Type:
Article
Add to My Research

International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013

JNCI : Journal of the National Cancer Institute, 2018-04, Vol.110 (4), p.354-361 [Peer Reviewed Journal]

ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djx214 ;PMID: 29045681

Full text available

10
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
Material Type:
Article
Add to My Research

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

Annals of Oncology, 2020-07, Vol.31 (7), p.894-901 [Peer Reviewed Journal]

2020 European Society for Medical Oncology ;Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2020 European Society for Medical Oncology ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1016/j.annonc.2020.03.296 ;PMID: 32224151

Digital Resources/Online E-Resources

11
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient
Material Type:
Article
Add to My Research

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3773-3784 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01255 ;PMID: 32931399

Full text available

12
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Material Type:
Article
Add to My Research

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Clinical cancer research, 2021-10, Vol.27 (20), p.5586-5594 [Peer Reviewed Journal]

2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-21-0410 ;PMID: 33926918

Full text available

13
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
Material Type:
Article
Add to My Research

Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

Journal of clinical oncology, 2023-04, Vol.41 (12), p.2238-2247 [Peer Reviewed Journal]

2022 by American Society of Clinical Oncology 2022 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.22.01725 ;PMID: 36548927

Full text available

14
Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study
Material Type:
Article
Add to My Research

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study

Journal of clinical oncology, 2017-07, Vol.35 (19), p.2117-2124 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2016.71.6795 ;PMID: 28375787

Full text available

15
Breast cancer statistics, 2019
Material Type:
Article
Add to My Research

Breast cancer statistics, 2019

CA: a cancer journal for clinicians, 2019-11, Vol.69 (6), p.438-451 [Peer Reviewed Journal]

2019 American Cancer Society ;2019 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2019 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21583 ;PMID: 31577379

Full text available

16
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Material Type:
Article
Add to My Research

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50

Journal of clinical oncology, 2021-07, Vol.39 (21), p.2339-2349 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00174 ;PMID: 33872070

Full text available

17
Chemotherapy and COVID-19 Outcomes in Patients With Cancer
Material Type:
Article
Add to My Research

Chemotherapy and COVID-19 Outcomes in Patients With Cancer

Journal of clinical oncology, 2020-10, Vol.38 (30), p.3538-3546 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01307 ;PMID: 32795225

Full text available

18
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Material Type:
Article
Add to My Research

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

Journal of clinical oncology, 2017-06, Vol.35 (17), p.1884-1890 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.71.7397 ;PMID: 28296582

Full text available

19
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017
Material Type:
Article
Add to My Research

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017

Neuro-oncology (Charlottesville, Va.), 2020-10, Vol.22 (Supplement_1), p.iv1-iv96 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noaa200 ;PMID: 33123732

Full text available

20
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
Material Type:
Article
Add to My Research

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis

Journal of clinical oncology, 2019-08, Vol.37 (23), p.2028-2040 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.18.01688 ;PMID: 31084544

Full text available

Results 1 - 20 of 195,315  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (183,243)

Refine My Results

Creation Date 

From To
  1. Before 1975  (572)
  2. 1975 To 1986  (4,996)
  3. 1987 To 1998  (21,407)
  4. 1999 To 2011  (66,284)
  5. After 2011  (102,060)
  6. More options open sub menu

Subject 

  1. Humans  (195,268)
  2. Middle Aged  (195,246)
  3. Science & Technology  (192,071)
  4. Life Sciences & Biomedicine  (190,082)
  5. Female  (172,842)
  6. Aged  (143,370)
  7. Male  (138,406)
  8. Adult  (132,109)
  9. Biological And Medical Sciences  (60,809)
  10. Medical Sciences  (60,466)
  11. Aged, 80 And Over  (57,622)
  12. Tumors  (49,203)
  13. Prognosis  (47,900)
  14. Medicine  (38,292)
  15. Medicine & Public Health  (35,919)
  16. Retrospective Studies  (32,884)
  17. Treatment Outcome  (30,707)
  18. Cancer Research  (30,622)
  19. Neoplasm Staging  (30,078)
  20. More options open sub menu

Language 

  1. English  (195,194)
  2. Japanese  (32,130)
  3. Portuguese  (539)
  4. Spanish  (309)
  5. Russian  (159)
  6. German  (93)
  7. Norwegian  (93)
  8. Chinese  (76)
  9. French  (23)
  10. Korean  (9)
  11. Polish  (1)
  12. Swedish  (1)
  13. Danish  (1)
  14. Italian  (1)
  15. Serbian  (1)
  16. Turkish  (1)
  17. Catalan  (1)
  18. More options open sub menu

Searching Remote Databases, Please Wait